Hitachi Chemical Advanced Therapeutics Solutions, LLC, a US subsidiary of Japanese firm Hitachi Chemical Co., Ltd....
PhoreMost Limited, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease target...
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as share...
Japan based Astellas Pharma Inc. has successfully completed the previously announced acquisition of Audentes Therapeutic...
Japan based Astellas Pharma Inc. has announced that the Third Fermentation Building (provisional name) will be construct...
US based company Charles River has announced a multi-year drug discovery collaboration with Japanese firm Takeda Pharmac...
Japan based Astellas Pharma Inc., through its wholly-owned subsidiary Universal Cells, Inc. and Adaptimmune Therapeutics...
ASKA Pharmaceutical Co., Ltd. and KinoPharma, Inc., both based in Tokyo, announced that they have entered into...
apceth Biopharma GmbH, a subsidiary of Japan headquartered Hitachi Chemical Co., Ltd. and a leading company for the manu...
ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-...
Japan based Astellas Pharma Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved its supplem...
Japanses firm Chugai Pharmaceutical Co., Ltd. has announced that the Company entered into a global licensing agreem...
US based HUYA Bioscience International CEO & Executive Chair, Dr. Mireille Gillings announced the appointm...
Alma, a global innovator of Laser, Light-based, Radiofrequency, Plasma and Ultrasound solutions for the aesthetic and su...
French firm Transgene, a biotech company that designs and develops virus-based immunotherapies for the treatment of canc...
US based aTyr Pharma, Inc., a biotherapeutics company engaged in the discovery and development of innovative medicines b...
Urovant Sciences, a subsidiary of Sumitomo Dainippon Pharma has announced that it has entered into a $300 million term l...
Kyoto University researchers have developed a new 'tumor-on-a-chip' device that can better mimic the environment inside ...
